CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 90 filers reported holding CYTOKINETICS INC in Q2 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,227,882 | -23.7% | 41,120 | -1.3% | 0.02% | -23.8% |
Q1 2024 | $2,921,343 | -20.9% | 41,668 | -5.8% | 0.02% | -25.0% |
Q4 2023 | $3,692,095 | +145.7% | 44,222 | -13.3% | 0.03% | +115.4% |
Q3 2023 | $1,502,519 | -11.7% | 51,002 | -2.2% | 0.01% | 0.0% |
Q2 2023 | $1,701,949 | -5.1% | 52,175 | +2.4% | 0.01% | -13.3% |
Q1 2023 | $1,793,141 | -33.3% | 50,956 | -13.2% | 0.02% | -37.5% |
Q4 2022 | $2,690,183 | +54.0% | 58,712 | +62.9% | 0.02% | +50.0% |
Q3 2022 | $1,747,000 | +697.7% | 36,042 | +283.0% | 0.02% | +1500.0% |
Q1 2021 | $219,000 | -43.8% | 9,410 | -49.9% | 0.00% | -50.0% |
Q4 2020 | $390,000 | -78.2% | 18,775 | -84.8% | 0.00% | -50.0% |
Q3 2017 | $1,790,000 | +30.7% | 123,456 | +9.0% | 0.00% | 0.0% |
Q2 2017 | $1,370,000 | +1531.0% | 113,255 | +543.2% | 0.00% | – |
Q2 2014 | $84,000 | -50.6% | 17,607 | -1.6% | 0.00% | – |
Q1 2014 | $170,000 | +107.3% | 17,897 | +41.6% | 0.00% | – |
Q4 2013 | $82,000 | -1.2% | 12,635 | +15.5% | 0.00% | – |
Q3 2013 | $83,000 | – | 10,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |